BAMI:MILBanco BPM SpA Analysis
Data as of 2026-06-17 - not real-time
€15.52
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Banco BPM is trading well above its 20‑day (13.73), 50‑day (13.13) and 200‑day (12.60) SMAs, confirming a strong bullish bias, while the MACD remains bullish and volume is increasing. However, the RSI at 84.5 signals an overbought condition and the price sits at the technical resistance of 15.52, matching the 52‑week high. Analysts’ consensus target (mean 13.78, median 13.60) lies below the current level, implying a potential downside of roughly 11 %.
Fundamentally, the bank delivers robust operating (52.9 %) and profit margins (37.8 %), a respectable ROE of 13.7 %, and a net‑cash position (cash 25.3 B € vs debt 28.8 B €). The valuation is attractive with a P/E of 11.2 versus an industry average of 17.1, and a dividend yield of 6.6 % supported by a 77 % payout ratio, suggesting the dividend is sustainable.
Fundamentally, the bank delivers robust operating (52.9 %) and profit margins (37.8 %), a respectable ROE of 13.7 %, and a net‑cash position (cash 25.3 B € vs debt 28.8 B €). The valuation is attractive with a P/E of 11.2 versus an industry average of 17.1, and a dividend yield of 6.6 % supported by a 77 % payout ratio, suggesting the dividend is sustainable.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI in overbought territory suggesting a near‑term pullback
- Current price at technical resistance and above analyst target
- High dividend yield providing downside protection
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Strong cash generation and net‑cash balance
- Attractive valuation relative to peers (P/E 11.2 vs 17.1 industry)
- Sustainable dividend with a 77% payout ratio
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Low beta (0.41) indicating defensive characteristics
- Consistent profitability and high dividend yield
- Solid balance sheet with net cash and low leverage
Key Metrics & Analysis
Financial Health
Revenue Growth2.90%
Profit Margin37.81%
P/E Ratio11.2
ROE13.72%
ROA1.00%
P/B Ratio1.5
Industry P/E17.1
Technical Analysis
TrendBullish
RSI84.5
Support€12.81
Resistance€15.52
MA 20€13.73
MA 50€13.13
MA 200€12.60
MACDBullish
VolumeIncreasing
Fear & Greed Index88.5
Valuation
Target Price€13.78
Upside/Downside-11.24%
GradeOvervalued
TypeValue
Dividend Yield6.63%
Risk Assessment
Beta0.41
Volatility21.41%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.